Basel Medical Group Ltd (BMGL) at a glance

Basel Medical Group Ltd (BMGL) is a micro-cap Healthcare company. It trades at $6.71, with a P/E of 115, a -93.7% profit margin and revenue growth of 27.3%. It does not pay a dividend. Vestovix scores it 48/100 overall. Its strongest dimension is Growth (78/100) and its weakest is Value (13/100).

Price

$6.72

Market cap

$11.1M

P/E ratio

115.0

Dividend yield

None

Beta

n/a

52-week range

$0.38 to $7.54